Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Neuropsychopharmacology
Journal
Overview
Identity
Overview
Publication Venue For
GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
. 45:2207-2218.
2020
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
. 45:1059-1067.
2020
Regulation of dopamine-dependent transcription and cocaine action by Gadd45b
2020
A longitudinal neurite and free water imaging study in patients with a schizophrenia spectrum disorder
. 44:1932-1939.
2019
The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia.
. 44:1562-1569.
2019
A dose-finding study of oxytocin using neurophysiological measures of social processing
. 44:289-294.
2019
Cognitive deficit in methamphetamine users relative to childhood academic performance: Link to cortical thickness
. 43:1745-1752.
2018
Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
. 43:1445-1456.
2018
Glutamate in pediatric obsessive-compulsive disorder and response to cognitive-behavioral therapy: Randomized clinical trial
. 42:2414-2422.
2017
Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects
. 42:1610-1618.
2017
Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder
. 42:864-875.
2017
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease
. 41:2171-2177.
2016
Erratum: Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease (Neuropsychopharmacology (2016) 41 (2188) DOI: 10.1038/npp.2016.18)
. 41:2188.
2016
Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity during Risky Decision Making
. 41:695-703.
2016
Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia
. 41:896-905.
2016
Influence of early life stress on intra- and extra-amygdaloid causal connectivity
. 40:1782-1793.
2015
Corrigenda - Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness (Neuropsychopharmacology Reviews (2014) 39, (65-87) DOI: 10.1038/npp.2013.239)
. 40:1307.
2015
Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia
. 39:1020-1030.
2014
N-glycosylation of GABA
A
receptor subunits is altered in schizophrenia
. 39:528-537.
2014
Cigarette exposure, dependence, and craving are related to insula thickness in young adult smokers
. 39:1816-1822.
2014
Postmortem brain: An underutilized substrate for studying severe mental illness
. 39:65-87.
2014
Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: Relationship to treatment and treatment response
. 39:2095-2103.
2014
Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia
. 38:1910-1920.
2013
Erratum: Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes (Neuropsychopharmacology (2013) 38 (1140) DOI: 10.1038/npp.2013.14)
. 38:1140.
2013
Regional decoupling of n-acetyl-aspartate and glutamate in schizophrenia
. 37:2635-2642.
2012
Yohimbine depresses excitatory transmission in bnst and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes
. 37:2253-2266.
2012
Activation of the orexin 1 receptor is a critical component of CO
2
-mediated anxiety and hypertension but not bradycardia
. 37:1911-1922.
2012
Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia
. 37:896-905.
2012
Gene-centric analysis of serum cotinine levels in African and European American populations
. 37:968-974.
2012
Epigenetic treatments for cognitive impairments
. 37:247-260.
2012
Review of pharmacological treatment in mood disorders and future directions for drug development
. 37:77-101.
2012
Functional biomarkers of depression: Diagnosis, treatment, and pathophysiology
. 36:2375-2394.
2011
Is CREB the angry bird that releases memory in alzheimer's
. 36:2153-2154.
2011
Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia
. 36:1779-1780.
2011
Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the clockδ19 mouse model of mania
. 36:1478-1488.
2011
Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals
. 36:950-959.
2011
Epigenetic modifications in neurons are essential for formation and storage of behavioral memory
. 36:357-358.
2011
Insulin regulation of monoamine signaling: Pathway to obesity
. 36:359-360.
2011
Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia
. 35:2110-2119.
2010
Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances
. 35:1761-1774.
2010
Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine
. 35:632-640.
2010
Modulation of limbic circuitry predicts treatment response to antipsychotic medication: A functional imaging study in schizophrenia
. 34:2675-2690.
2009
Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects
. 33:2324-2340.
2008
Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder
. 33:2175-2186.
2008
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine
. 33:1760-1772.
2008
Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects
. 32:2338-2350.
2007
High-dose methadone maintenance in rats: Effects on cocaine self-administration and behavioral side effects
. 32:2290-2300.
2007
Reply: 'Second generation antipsychotic drugs: Is there a common mechanism in the development of obesity?' [2]
. 32:2433-2434.
2007
Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders
. 32:1888-1902.
2007
Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis
. 32:765-772.
2007
Reply to Balcar and Nanitsos. Reply: Autoradiography of [
3
H]aspartate and glutamate transport in schizophrenia [2]
. 31:687-688.
2006
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia
. 31:221-230.
2006
Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia
. 30:2275-2282.
2005
Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement
. 30:1681-1692.
2005
Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims
. 30:1548-1556.
2005
Cortical glutamatergic markers in schizophrenia
. 30:1521-1531.
2005
Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors
. 30:1443-1454.
2005
Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: Role in LH behavior
. 30:473-483.
2005
Gene expression changes induced by repeated cocaine administration through the dopamine D1 receptors
. 30:1443-1454.
2005
Decreased serotonin 5-HT
2A
receptor-stimulated phosphoinositide signalling in fibroblasts from melancholic deppresed patients
. 29:2081-2087.
2004
Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder
. 29:1353-1362.
2004
Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use
. 29:1312-1320.
2004
Gender-Specific Gene Expression in Post-Mortem Human Brain: Localization to Sex Chromosomes
. 29:373-384.
2004
Differential Expression of Pentraxin 3 in Fibroblasts from Patients with Major Depression
. 29:126-132.
2004
7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment
. 28:100-107.
2003
Erratum: mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims (Neuropsychopharmacology (October 2002) 27:4 (499-517) PII:S0893133X02003354)
. 27:1092.
2002
mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims
. 27:499-517.
2002
Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959
. 26:301-310.
2002
Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
. 26:368-375.
2002
Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients
. 26:216-228.
2002
Abnormal kainate receptor expression in prefrontal cortex in schizophrenia
. 24:545-552.
2001
Ketamine effects on eye movements
. 23:645-653.
2000
New initiative: Neuropsychopharmacology online rapid publication
. 23:221-222.
2000
Ionotropic glutamate receptor modulation of 5-HT
6
and 5-HT
7
mRNA expression in rat brain
. 21:341-351.
1999
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia
. 21:195-202.
1999
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics
. 19:278-286.
1998
Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells
. 17:12-17.
1997
Linking the family of D
2
receptors to neuronal circuits in human brain: Insights into schizophrenia
. 16:375-384.
1997
Dopamine receptor mRNA expression in human striatum and neocortex
. 15:17-29.
1996
β-Adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression
. 15:555-561.
1996
Dopamine receptor gene expression in the human medial temporal lobe
. 10:239-248.
1994
Comparison of the distributions of D
1
and D
2
dopamine receptor mRNAs in the rat brain
. 5:231-242.
1991
Identity
International Standard Serial Number (issn)
0893-133X
Electronic International Standard Serial Number (eissn)
1740-634X